A single-arm exploratory clinical study of β-glucan combined with camrelizumab and SOX chemotherapy as first-line treatment for advanced gastric adenocarcinoma.

被引：0
|
作者：
Zhu, Wenyu
Chu, Yunqian
He, Xuan
Jiang, Hua
Zhu, Chan
Zhang, Xing
Wu, Fangfang
Dai, Hanjue
Xian, Qingying
Xue, Ya
机构：
[1] Nanjing Med Univ, Affiliated Changzhou Peoples Hosp 2, Dept Oncol, Changzhou, Jiangsu, Peoples R China
[2] Dalian Med Univ, Grad Sch, Dalian, Peoples R China
[3] Jiangsu Simcere Diagnost Co Ltd, Nanjing, Jiangsu, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16008
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of camrelizumab combined with chemotherapy (irinotecan combined with platinum) followed by camrelizumab combined with apatinib in the first-line treatment of advanced small cell lung cancer: A phase II study.
    Ni, Jun
    Zhang, Xiaotong
    Pan, Ruili
    Wang, Hanping
    Si, Xiaoyan
    Cui, Xiaoxia
    Zhang, Li
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [42] Camrelizumab combined with anlotinib and nab-paclitaxel in patients with untreated advanced mucosal melanoma: A single-arm, multicenter, exploratory study.
    Wu, Di
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [43] Apatinib in Combination with S-1 as First-Line Treatment in Patients with Advanced Metastatic Gastric Cancer: Results from an Open, Exploratory, Single-Arm, Phase II Trial
    Zhou, Na
    Zhang, Chuantao
    Liu, Dong
    Liu, Kewei
    Wang, Guanqun
    Zhu, Hua
    Zhang, Jianli
    Jiang, Man
    Liu, Ning
    Zhang, Xiaochun
    ONCOLOGIST, 2021, 26 (03): : E374 - E381
  • [44] Camrelizumab combined with ablation and chemotherapy for pancreatic cancer with liver metastases: A single-arm, phase II, prospective clinical study.
    Li, Zhiwei
    Li, Qingwei
    Ma, Zhigang
    Ma, Yue
    Su, Dan
    Lou, Changjie
    Wang, Guangyu
    Liu, Chao
    Zhang, Yanqiao
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [45] Paclitaxel combined with capecitabine as first-line chemotherapy for advanced or recurrent gastric cancer
    Yuan, Meiqin
    Yang, Yunshan
    Lv, Wangxia
    Song, Zhengbo
    Zhong, Haijun
    ONCOLOGY LETTERS, 2014, 8 (01) : 351 - 354
  • [46] Microwave ablation combined with apatinib and camrelizumab in patients with advanced hepatocellular carcinoma: A single-arm, preliminary study
    Li, Xin
    Zhang, Qiao
    Lu, Qiaorui
    Cheng, Zhigang
    Liu, Fangyi
    Han, Zhiyu
    Yu, Xiaoling
    Yu, Jie
    Liang, Ping
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [47] PD-1 antibody camrelizumab plus apatinib and SOX as first-line treatment in patients with AFP-producing gastric or gastro-esophageal junction adenocarcinoma (CAP 06): a multi-center, single-arm, phase 2 trial
    Yakun Wang
    Jialin Lu
    Xiaoyi Chong
    Chang Wang
    Xiaofeng Chen
    Zhi Peng
    Yanhong Gu
    Yizhuo Wang
    Xicheng Wang
    Jian Li
    Jifang Gong
    Changsong Qi
    Jiajia Yuan
    Zhihao Lu
    Ming Lu
    Jun Zhou
    Yanshuo Cao
    Yang Chen
    Cheng Zhang
    Zhiguo Hou
    Hongyi Kou
    Lin Shen
    Xiaotian Zhang
    Signal Transduction and Targeted Therapy, 10 (1)
  • [48] Multicenter phase I dose escalation and expansion study of pyrotinib in combination with camrelizumab and chemotherapy as first-line treatment for HER2-positive advanced gastric and gastroesophageal junction adenocarcinoma
    Li, Sheng
    Bao, Jun
    Li, Xiaoyou
    Yang, Quanliang
    Xu, Junying
    Chen, Surong
    Feng, Ge
    Gao, Chao
    Feng, Lin
    Lu, Bin
    Miao, Min
    Ni, Xinchu
    Wang, Guofang
    Yang, Lei
    Zhu, Liangjun
    ECLINICALMEDICINE, 2023, 66
  • [49] Combination Chemotherapy with S-1 and Oxaliplatin (SOX) as First-Line Treatment in Elderly Patients with Advanced Gastric Cancer
    Zhong, Dong-ta
    Wu, Ri-ping
    Wang, Xin-li
    Huang, Xiao-bing
    Lin, Meng-xin
    Lan, Yan-qin
    Chen, Qiang
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (04) : 867 - 873
  • [50] The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma (COMPASSION-08): a phase Ib/II single-arm clinical trial
    Qiao, Qian
    Han, Chun
    Ye, Sisi
    Li, Juan
    Shao, Guoliang
    Bai, Yuxian
    Xu, Aibing
    Sun, Meili
    Wang, Wei
    Wu, Jian
    Huang, Ming
    Song, Lijie
    Huang, Luke
    Liu, Ting
    Liu, Wei
    Wang, Zhongmin Maxwell
    Li, Baiyong
    Xia, Michelle
    Bai, Li
    FRONTIERS IN IMMUNOLOGY, 2023, 14
12345